Patent: 10,376,579
✉ Email this page to a colleague
Summary for Patent: 10,376,579
Title: | Nanoparticle complexes of albumin, paclitaxel, and anti-VEGF antibody for treatment of cancer |
Abstract: | This document provides materials related to treating cancer (e.g., skin cancer). For example, materials relating to the use of a composition containing albumin-containing nanoparticle/antibody complexes (e.g., albumin-bound paclitaxel/anti-VEGF polypeptide antibody complexes) to treat cancer (e.g., skin cancer) are provided). |
Inventor(s): | Markovic; Svetomir N. (Rochester, MN), Nevala; Wendy K. (Rochester, MN) |
Assignee: | Mayo Foundation for Medical Education and Research (Rochester, MN) |
Application Number: | 15/052,336 |
Patent Claims: | see list of patent claims |
Details for Patent 10,376,579
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 02/26/2004 | ⤷ Try a Trial | 2032-10-01 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |